Patients with end stage kidney disease under hemodialysis. End stage renal disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Aged over 18 years; Receive hemodialysis at least twice a week, for about 3 months; Negative history of using medications with known effect on inflammatory markers such as corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs) in the last month; No active infectious diseases, malignant, rheumatic diseases and other inflammatory diseases.
Exclusion criteria
Exclusion criteria: Patients who require additional supplementary therapies (taking medications that affect the inflammatory process during the study)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bun, cholesterol, Low Density Lipoproteinn, High Density lipoProtein, triglyceride, potassium, albumin, calcium and phosphorus and antioxidant tests including malondialdehyde, glutathione peroxidase, superoxide dismutase, high sensitive-CRP, Total Oxidant capacity, Total Antioxidant capacity, P-SH. Timepoint: At the beginning of the study and 28 days later. Method of measurement: Antioxidant and biochemical tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yasouj University of Medical Sciences